Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
Articles
Serial biomarker measurements in chronic heart failure
Wayne L. Miller, PhD, MD;Allan S. Jaffe, MD: From the Division of Cardiovascular Diseases;Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
September 5th 2008Cardiac troponin T (cTnT) and B-type natriuretic peptide (BNP) have been used to estimate prognosis in heart failure. However, most studies have evaluated decompensated patients using single measurements. To determine the value of serial measurements, we evaluated 190 stable chronic heart failure patients every 3 months during 2 years.
Read More
Latest Updated Articles
Published: October 4th 2024 | Updated: October 14th 2024
Minimally Invasive Techniques to Manage Complex Polyps at Allegheny Health Network
Published: May 2nd 2024 | Updated: May 6th 2024
Cardiology Month in Review: April 2024
Published: September 23rd 2014 | Updated: December 9th 2024
Itchy, Oozing Rash
Published: December 4th 2024 | Updated: December 9th 2024
Endoscopy in the Age of GLP-1 RAs: 2024 Sees New Risk-Based Perioperative Guidance
Published: December 3rd 2024 | Updated: December 9th 2024
This Year in Medicine 2024: Stories that Defined Healthcare
Published: December 3rd 2024 | Updated: December 9th 2024
Intra-Cellular Therapies Submits sNDA to FDA for Lumateperone as an MDD Adjunctive Therapy
